DK
Kanojia Deepak
Also known as: Deepak Kanojia
Mythic Therapeutics, Northwestern University, Homi Bhabha National Institute, Northwestern University - Chicago
Employment
-
Mythic Therapeutics Principal Scientist2021 - Present
-
Northwestern University Research Assistant Professor2020 - 2021
-
Northwestern University - Chicago Research Associate2016 - 2021
-
The University of Chicago Postdoctoral Scholar2012 - 2015
-
University of South Carolina Postdoctoral Fellow2010 - 2012
Education
-
Homi Bhabha National Institute Biochemistry2005 - 2010
Projects & Funding
Projects & funding information is unavailable.
Publications (66)
- Supplementary Figure S2 from MYTX-011: A pH-Dependent Anti–c-MET Antibody–Drug Conjugate Designed for Enhanced Payload Delivery to c-MET–Expressing Tumor Cells Save
- Supplementary Figure S1 from MYTX-011: A pH-Dependent Anti–c-MET Antibody–Drug Conjugate Designed for Enhanced Payload Delivery to c-MET–Expressing Tumor Cells Save
- Supplementary Table S3 from MYTX-011: A pH-Dependent Anti–c-MET Antibody–Drug Conjugate Designed for Enhanced Payload Delivery to c-MET–Expressing Tumor Cells Save
- Supplementary Table S2 from MYTX-011: A pH-Dependent Anti–c-MET Antibody–Drug Conjugate Designed for Enhanced Payload Delivery to c-MET–Expressing Tumor Cells Save
- Supplementary Table S1 from MYTX-011: A pH-Dependent Anti–c-MET Antibody–Drug Conjugate Designed for Enhanced Payload Delivery to c-MET–Expressing Tumor Cells Save
- Supplementary Figure S4 from MYTX-011: A pH-Dependent Anti–c-MET Antibody–Drug Conjugate Designed for Enhanced Payload Delivery to c-MET–Expressing Tumor Cells Save
- Supplementary Figure S3 from MYTX-011: A pH-Dependent Anti–c-MET Antibody–Drug Conjugate Designed for Enhanced Payload Delivery to c-MET–Expressing Tumor Cells Save
- Supplementary Methods from MYTX-011: A pH-Dependent Anti–c-MET Antibody–Drug Conjugate Designed for Enhanced Payload Delivery to c-MET–Expressing Tumor Cells Save
- Data from MYTX-011: A pH-Dependent Anti–c-MET Antibody–Drug Conjugate Designed for Enhanced Payload Delivery to c-MET–Expressing Tumor Cells Save
- MYTX-011: A pH-Dependent Anti–c-MET Antibody–Drug Conjugate Designed for Enhanced Payload Delivery to c-MET–Expressing Tumor Cells Save